Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cannabist Co Holdings (CBSTF) Gains from Sales and Divestitures (2020 - 2023)

Cannabist Co Holdings' Gains from Sales and Divestitures history spans 4 years, with the latest figure at $2.3 million for Q4 2023.

  • For Q4 2023, Gains from Sales and Divestitures rose 1325.34% year-over-year to $2.3 million; the TTM value through Dec 2023 reached $2.3 million, up 1325.34%, while the annual FY2023 figure was $2.3 million, 1325.34% up from the prior year.
  • Gains from Sales and Divestitures for Q4 2023 was $2.3 million at Cannabist Co Holdings, down from $5.7 million in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $5.7 million in Q3 2023 and bottomed at $114957.0 in Q4 2021.
  • The 4-year median for Gains from Sales and Divestitures is $2.2 million (2023), against an average of $2.2 million.
  • The largest annual shift saw Gains from Sales and Divestitures tumbled 81.02% in 2021 before it skyrocketed 1369.76% in 2023.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $605665.0 in 2020, then crashed by 81.02% to $114957.0 in 2021, then soared by 40.85% to $161920.0 in 2022, then surged by 1325.34% to $2.3 million in 2023.
  • Per Business Quant, the three most recent readings for CBSTF's Gains from Sales and Divestitures are $2.3 million (Q4 2023), $5.7 million (Q3 2023), and $5.5 million (Q2 2023).